Loading clinical trials...

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome. | Clinical Trials | Clareo Health

Back to clinical trial search

SUSPENDEDPhase 3NCT05463679

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.

The purpose of this study is to investigate the efficacy of enzastaurin compared to placebo in preventing arterial events (rupture, dissection, pseudoaneurysm, carotid-cavernous sinus fistula, or aneu...

Lead sponsor: Aytu BioPharma, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients

NCT05994664 · Vascular Ehlers-Danlos Syndrome

COMPLETED

Biomarkers in Vascular Ehlers-Danlos Syndrome

NCT02165085 · Vascular Ehlers-Danlos Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 8, 2024Terms

Trial snapshot

StatusSUSPENDED

PhasePHASE3

Enrollment260

Start dateJan 2025

Last updatedMar 8, 2024

Condition

Vascular Ehlers-Danlos Syndrome

Locations shown

Aytu BioPharma

Englewood, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 8, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions